Sodium Borohydride Market in China
- 142782
- 30-Apr
- Chemicals and Materials
- 27
- ccm
-
Report Details
Currently, China's sodium borohydride industry is facing overcapacity. The capacity increased slightly from 6,100 t/a in 2016 to 7,100 t/a in 2020, with a CAGR of 3.87%. In 2020, the output of sodium borohydride was 3,730 tonnes, and the operating rate in the whole industry was just about 53%. Still, it's not easy for new entrants to get a foothold in the domestic market, since the top three producers have taken up the majority of the national output. Sodium borohydride produced in China is mainly used within the country. As a selective reducing agent, sodium borohydride is mainly consumed in pharmaceuticals and agrochemicals, and these two fields accounted for the majority of the total consumption volume in 2020. Other fields, such as intermediates & fine chemicals and electronic products, consumed small volumes of the product. Yet, sodium borohydride faces competition from substitutes, especially potassium borohydride, which has the same properties but has a lower price. In this report, more comprehensive information is provided. Reasons to buy this report ?Gain insight into general market of sodium borohydride in China in the past years, including production, price and consumption; ?Identify key producers of sodium borohydride in China; ?Understand consumption of sodium borohydride during 2016 and 2020, as well as its consumption structure by applications. Market Key Players: Shandong Guobang Pharmaceutical Co., Ltd. Jiangsu Huachang Chemical Co., Ltd. Ningxia Best Pharmaceutical Chemical Co., Ltd. Jiangsu Hongzi New Energy Science & Technology Co., Ltd. Rugao Chemical Reagent Factory Co., Ltd.
-
Table Of Content
Executive summary Methodology and definition 1 Key findings and market dynamics 1.1 Key findings 1.2 Market dynamics 2 Production 2.1 Capacity and output, 2016?2020 2.2 Producer 2.2.1 Production situation, 2016?2020 2.2.2 Competition analysis 2.3 Price analysis 2.4 Technology 3 Consumption 3.1 Overview, 2016?2020 3.2 Downstream industries 3.2.1 Pharmaceuticals 3.2.2 A
-
Inquiry Before Buying
-
Request Sample